Lung Cancer Network Malaysia says there’s a lack of infrastructure to support the clinical trial environment in Malaysia and that many doctors are not motivated to do research.
Millions of lives in Japan, the EU, Brazil, Canada, India, and China could be saved if patients were able to be treated with pembrolizumab and enzalutamide, a new study found.
Sarawak General Hospital (SGH), Clinical Research Malaysia, and Novartis have signed an MOU, where SGH will be the multinational pharmaceutical company’s preferred clinical research centre.
Last year, infectious diseases topped new sponsored clinical research in Malaysia, reversing the trend since 2012 when oncology comprised the majority of studies, involving novel therapies.
Dr Voon Pei Jye from Sarawak General Hospital notes that there are very limited Malaysian Phase One oncology clinical trials published in international journals from 2011 to 2020.